Appeal No. 1995-2437
Application No. 08/035,723
judgment, the only reason or suggestion to modify the references to arrive at the present
invention comes from appellant’s specification.
Accordingly, the rejection of claims 1 through 8 under 35 U.S.C. § 103 is reversed.
35 U.S.C. §§ 102(f) and 112, first paragraph
U.S. Patent No. 5,872,222 (the ‘222 patent) issued from application serial no.
07/993,291, an application closely related to the present application. Claims 1 and 7 of
the ‘222 patent read as follows:
1. A conjugate comprising a substantially nonimmunogenic polymer coupled
with a plurality of binding molecules, each being specific for an antigen on a
T cell, and said binding molecules lacking an Fc portion.
7. An improved method for producing antibodies against an immunogen,
comprising administering the conjugate of claim 1 to a host animal together
with the immunogen and thereby increasing the immunogenic response
against the antigen, and screening for antibodies, or cells producing
antibodies, which are specifically reactive with the immunogen.
It is apparent from a review of ‘222 that the patented method and the methods that
are the subject of this appeal are closely related and parallel each other. Thus it appears
that the continued rejection of the claims in the present application under 35 U.S.C. §
5
Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007